Objective: Transitory otoacoustic emissions (TEOAE) can be significant for diagnosing the hearing defect and for monitoring healing treatment for some diseases of ear conduction apparatus. They were investigated for non-compensated and compensated pressure in a middle ear in the two groups of diseases (inflammatory and non-inflammatory). 
INTRODUCTION
Otoacoustic emissions (OAE) are widely applied today and have become an essential segment of complete auditory processing. Transient otoacoustic emission (TEOAE) is a segment of the class of evoked otoacoustic emissions and is generated as a response of cochlear to brief duration incentive signal in the external auditory canal (1) and like the other otoacoustic emissions can show the state of sensory segment of auditory apparatus. Their frequencies are not specific what is in contrast to DPOAE (distortion products).
Comparative analysis of (2) which included 579 newborn babies exposed to TEOAE and DPOAE screening showed a significantly strong positive relationship between these two procedures. By the application of the Spearman Rank's correlation coefficient they determined the pass index of 95 % for TEOAE and of 91 % for DPOAE. Comparing these two procedures showed that 91 % of newborn babies passed both procedures, 4.5 % babies passed only TEOAE and 0.5 % babies passed only DPOAE, while 4 % passed neither procedure.
We use them when we wish to test an entire cochlear since their incentive signal is a brief duration impulse signal which can prompt a whole basilar membrane. They represent complex acoustic incidents which can be registered in almost every human individual with normal hearing. The energy in the region of frequencies close to 1500 Hz dominates the response to acoustic click stimulus and amplitude of response is in relationship to magnitude of stimulus in a complex relationship (1).
Otoacoustic emissions are widely used in early diagnostics of hearing defects. Their application is non-invasive, of brief duration, can be done during sleep what is of special benefit to newborn babies and little children. Correct and early diagnosis of hearing defects is a precondition for starting timely habilitation of hearing and consequent correct morphofunctional development of complete auditory system, then of speaking and intelectual and emotional development.
When pathology of a middle ear is in question OAE are used to monitor recovery of acute or secretory chronic otitis media. In a disease evolution tone audiometry is being first recovered, then tympanometry and in the end otoacoustic emissions, therefore their normalisation can be considered as a sign of final healing (3).
The research conducted by a group of authors has shown that conduction pathology has a greatest influence on transfer characteristic in the range of medium frequencies therefore its most prominent influence on TEOAE is in the range of medium frequencies (4).
Emission is most prominent in the range of medium frequencies meaning that it is immediately dependent on the function of middle ear which takes part in transfer of recurrent transmission of emission response of cochlear to stimulus (5).
There are various middle ear defects: perforation of tympanic membrane, negative pressure in middle ear, otitis media acute, chronic suppurative and non-suppurative otitis media, chronic secretory otitis media, catarrh or auditory tube, fixation -discontinuity of the chain of auditory ossicles, tumours, otosclerosis, tympanosclerosis, injure of mastoid region, etc. The application of otoacoustic emissions in differential diagnostics of sensorineural deafness is primarily in differentiating cochlear and retrocochlear defects. Some research (6) suggest that the method of transitory otoacoustic emisions can be reliable in detection and sensorineural and conductive hearing loss. Otoacoustic emissions can be registered in proper function of middle and inner ear, while on the contrary, they are absent or reduced in defects of cochlear and/or middle ear, even in less severe forms.
The aim of this study was to determine the value of TEOAE parameters at noncompensated (ambiental) and compensated pressure. In addition, the differences in registered parameters of otoacoustic emissions within diseases of ear conduction apparatus were discussed. 
MATERIAL AND METHODS

The
RESULTS
Within all the persons tested between the two groups of diseases of conduction apparatus: inflammatory (Z; 65%) and non-inflammatory (NZ; 35%) a statistically significant difference in frequencies of manifesting disorders (χ²=12.907, p<0.0001) was determined.
Within each group of disorders, different changes of ear conduction apparatus ( Figure   1 ) were diagnosed during test. Comparing the frequencies of diagnosed disorders, a statistically significant differences were determined between individual diseases (χ²=27.867; p=0.001). Values of amplitude confirmed by our study are similar to the study of (9) The results showed that between the treatments with pressure compensation there existed no significant differences in amplitudes so that obtained results partly correspond with the study of (8) where the highest increase was observed in the frequency range of 1 to 2 kHz, a statistically significant correlation was perceived between compensated pressure and increased TEOAE amplitude. At higher frequencies (3 and 4 kHz), TEOAE amplitudes were not sensitive to pressure compensation. The study of (10) in which the patients with tympanometrical peak ranged from -100 to -300 daPa were tested, in all cases pressure compensation in middle ear increased the emission amplitudes. The study of (11) indicates that low values of negative pressure in middle ear can significantly affect spectrum of stimulus and response. At lower frequencies the compensation can result in the increase of the TEOAE amplitude compared with the amplitudes at ambiental pressure.
Some studies show that if the quantity of secretion in cavum tympani is elevated the decrease in amplitude and reproducibility of TEOAE response is also higher. Thus research (12) suggest that mucoid content in middle ear can reduce TEOAE more than non-mucoid secretion, while both can disable a proper transfer of sound wave to cochlear, and therefore its adequate treatment. Study by (13) indicates the differences in TEOAE registration between lesions such as tympanosclerosis, OMA, otosclerosis and chain discontinuity depending on the gravity of disease and the model utilised to register otoacoustic emissions.
In our study a statistically significant differences in registered TEOAE parameters compared between the groups of non-inflammatory and inflammatory diseases within both treatments with pressure were not determined. It is possible that differences between individual lesions could be confirmed but in our study they were grouped due to a small sample of persons tested for singular diseases.
Low values of negative pressure in middle ear can spread to the TEOAE spectrum and potentially affect test accuracy. Study of (11) suggests that in longer monitoring (monitoring TEOAE) the pressure in middle ear should be close to ambiental pressure or compensated by equivalent pressure in external auditory canal.
CONCLUSION
Pressure compensation in middle ear has significantly affected obtaining TEOAE response and the size of this response. Mean values of correlation response and level of stimulus were significantly higher at pressure compensation regardless the disorder in ear conduction
